The Effectiveness of the Board Game on Primary Healthcare Nurses' Knowledge, Attitudes, and Confidence in Dengue-related Practice: a Cluster Randomized Controlled Trial
Launched by TAIPEI MEDICAL UNIVERSITY · Jun 11, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether playing an educational board game can help nurses working in primary healthcare centers improve their knowledge, attitudes, and confidence when caring for patients with dengue, a mosquito-borne illness. The study compares this fun, interactive learning method to a more traditional lecture-style session to see which one works better. Nurses will also share how satisfied they feel about their learning experience.
Nurses who work full-time in primary healthcare units, have at least three months of experience in their current role, have cared for patients suspected of having dengue, and are comfortable using smartphones and WhatsApp may be eligible to join. Participants will be randomly assigned to either the board game group or the lecture group and will take part in a single 90-minute session. Their knowledge, attitudes, and confidence about dengue care will be measured before and after the session to see how much they improve. Nurses on maternity or annual leave during the study won’t be able to participate. This study is set to take place in Yogyakarta, Indonesia, and is not yet recruiting volunteers.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Full-time employed nurses in the PHC unit
- • Nurses who have experience in assessing dengue-suspected patients
- • Nurses who have at least three months of work experience in the current PHC unit
- • Nurses who have a smartphone for online communication
- • Nurses who are familiar with WhatsApp applications
- Exclusion Criteria:
- • Nurses on maternity or annual leave during the data collection period.
About Taipei Medical University
Taipei Medical University (TMU) is a leading educational and research institution located in Taipei, Taiwan, dedicated to advancing health sciences and clinical research. Established with a focus on fostering innovation in medical education, TMU integrates comprehensive clinical training with rigorous research methodologies. The university is committed to improving patient outcomes through a strong emphasis on translational medicine and interdisciplinary collaboration. TMU's clinical trial initiatives are designed to explore new treatments and therapies, contributing to the global body of medical knowledge while adhering to the highest ethical standards and regulatory compliance.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Yogyakarta, , Indonesia
Patients applied
Trial Officials
Nuzul S Hertanti, RN, MS
Principal Investigator
Taipei Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported